Clinical Trial Update: Cell-free DNA Methylation for Epithelial Ovarian Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update investigating cell-free DNA methylation as a biomarker in epithelial ovarian cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epithelial Ovarian Cancer

Snippet

Sponsor: Lei Li | Conditions: Epithelial Ovarian Cancer, DNA Methylation | Phase 2 | Status: UNKNOWN